(Q38761419)

6 September 2017

1 reference

title

Roles of tumour necrosis factor in the illness and pathology of malaria (English)

1 reference

6 September 2017

0 references

0 references

Clark IA

1

1 reference

PubMed ID

2694475

6 September 2017

Chaudhri G

series ordinal

2

1 reference

PubMed ID

2694475

6 September 2017

Cowden WB

series ordinal

3

1 reference

6 September 2017

1 July 1989

1 reference

Transactions of the Royal Society of Tropical Medicine and Hygiene

6 September 2017

1 reference

6 September 2017

83

1 reference

6 September 2017

436-440

1 reference

6 September 2017

4

1 reference

Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin

6 September 2017

1 reference

https://api.crossref.org/works/10.1016%2F0035-9203%2889%2990240-X

Does endotoxin cause both the disease and parasite death in acute malaria and babesiosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0035-9203%2889%2990240-X

Cell-mediated immunity in protection and pathology of malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0035-9203%2889%2990240-X

Tumour necrosis factor may contribute to the anaemia of malaria by causing dyserythropoiesis and erythrophagocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0035-9203%2889%2990240-X

The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0035-9203%2889%2990240-X

Tolerance to tumor necrosis factor in rats and the relationship to endotoxin tolerance and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0035-9203%2889%2990240-X

Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0035-9203%2889%2990240-X

Detection of circulating tumor necrosis factor after endotoxin administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0035-9203%2889%2990240-X

Antibody to tumor necrosis factor (TNF) reduces endotoxin fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0035-9203%2889%2990240-X

Interleukin-1 induces analgesia in mice by a central action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0035-9203%2889%2990240-X

Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0035-9203%2889%2990240-X

The pathophysiology of severe falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0035-9203%2889%2990240-X

Thrombospondin binds falciparum malaria parasitized erythrocytes and may mediate cytoadherence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0035-9203%2889%2990240-X

Raised serum levels of tumour necrosis factor in parasitic infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0035-9203%2889%2990240-X

Tumour necrosis factor in man: clinical and biological observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0035-9203%2889%2990240-X

Recombinant Human Tumor Necrosis Factor Administered as a 24-Hour Intravenous Infusion. A Phase I and Pharmacologic Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0035-9203%2889%2990240-X

Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0035-9203%2889%2990240-X

Production and clearance of tumor necrosis factor in rats exposed to endotoxin and dexamethasone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0035-9203%2889%2990240-X

Polypetide mediator network

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0035-9203%2889%2990240-X

10.1016/0035-9203(89)90240-X

21 January 2018

Identifiers

DOI

1 reference

6 September 2017

1 reference

PubMed ID

2694475